DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Marcus L, Lemery SJ, Keegan P. et al.
FDA approval summary: Pembrolizumab for the treatment of microsatellite instability-high solid tumors.
Clin Cancer Res 2019;
25: 3753-3758
We do not assume any responsibility for the contents of the web pages of other providers.